Cargando…

Blood pressure surveillance in cancer patients treated with immune checkpoint inhibitors

Immune checkpoint inhibitors (ICI) are cancer therapies that have been associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). Blood pressure (BP) measurements are routinely performed during day oncology center visits for administration of ICI therapy but are often not asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Sean, Spear, Ella, Sane, Nikhita, Nelson, Adam J., Nerlekar, Nitesh, Segelov, Eva, Nicholls, Stephen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632129/ https://www.ncbi.nlm.nih.gov/pubmed/37076569 http://dx.doi.org/10.1038/s41371-023-00831-z

Ejemplares similares

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review
por: Tan, Sean, et al.
Publicado: (2022)

Incessant myopericarditis after mRNA vaccination requiring IL-1 receptor antagonist therapy and pericardiectomy: case report
por: Hay, Michael B, et al.
Publicado: (2023)

Immune checkpoint inhibitor–mediated myocarditis and ventricular tachycardia storm
por: McDowall, Lachlan M., et al.
Publicado: (2019)

Are we over-treating with checkpoint inhibitors?
por: Danson, Sarah, et al.
Publicado: (2019)

Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
por: Wu, Yin, et al.
Publicado: (2022)

Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
por: Yuvaraj, Jeremy, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas
por: Witkowska, Magdalena, et al.
Publicado: (2018)

Cardiac Surveillance in Immune Checkpoint Inhibitor Therapy: Biomarkers Versus Imaging
por: Vallejo-Camazón, Nuria, et al.
Publicado: (2022)

Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors
por: Waliany, Sarah, et al.
Publicado: (2021)

Prognostic Value of Exercise Capacity in Kidney Transplant Candidates
por: Tan, Sean, et al.
Publicado: (2022)

Atherogenic index of plasma is associated with epicardial adipose tissue volume assessed on coronary computed tomography angiography
por: Yuvaraj, Jeremy, et al.
Publicado: (2022)

Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
por: Hasan Ali, Omar, et al.
Publicado: (2020)

Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2020)

Pericardial disease in patients treated with immune checkpoint inhibitors
por: Gong, Jingyi, et al.
Publicado: (2021)

Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
por: Shen, Pan, et al.
Publicado: (2021)

Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors
por: Boumaza, Xavier, et al.
Publicado: (2022)

Visible age-related signs in an Arab patient presenting with a myocardial infarction
por: Nerlekar, Nitesh, et al.
Publicado: (2015)

Inter-software and inter-scan variability in measurement of epicardial adipose tissue: a three-way comparison of a research-specific, a freeware and a coronary application software platform
por: Chan, Jasmine, et al.
Publicado: (2023)

Rheumatic complications in cancer patients treated with immune checkpoint inhibitors
por: Lee, Kyung-Ann, et al.
Publicado: (2019)

How we treat endocrine complications of immune checkpoint inhibitors
por: Paschou, S.A., et al.
Publicado: (2021)

Acute kidney injury in patients treated with immune checkpoint inhibitors
por: Gupta, Shruti, et al.
Publicado: (2021)

Pancreatic adverse events in patients treated with immune checkpoint inhibitors
por: Hana, Caroline, et al.
Publicado: (2023)

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
por: Drobni, Zsofia D., et al.
Publicado: (2022)

Normal pressure hydrocephalus treated with ventriculoperitoneal shunt
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2023)

Association of Volumetric Epicardial Adipose Tissue Quantification and Cardiac Structure and Function
por: Nerlekar, Nitesh, et al.
Publicado: (2018)

Association of Epicardial Adipose Tissue and High‐Risk Plaque Characteristics: A Systematic Review and Meta‐Analysis
por: Nerlekar, Nitesh, et al.
Publicado: (2017)

On the Road to Immunotherapy—Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies
por: Ward, Frank J., et al.
Publicado: (2018)

Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †
por: de Glas, Nienke A., et al.
Publicado: (2021)

Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report
por: Holmstroem, Rikke Boedker, et al.
Publicado: (2022)

Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors
por: Mamoor, Maha, et al.
Publicado: (2020)

How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors
por: Jordan, B., et al.
Publicado: (2021)

Host response to immune checkpoint inhibitors contributes to tumor aggressiveness
por: Khononov, Irina, et al.
Publicado: (2021)

Advances in immune checkpoint inhibitors for bone sarcoma therapy
por: Thanindratarn, Pichaya, et al.
Publicado: (2019)

Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
por: Harada, Mirii, et al.
Publicado: (2023)

Pericoronary adipose tissue attenuation on coronary computed tomography angiography associates with male sex and Indigenous Australian status
por: Yuvaraj, Jeremy, et al.
Publicado: (2023)

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy
por: Cunningham, Morven, et al.
Publicado: (2021)

Hyperprogression in Pediatric Melanoma Metastatic to the Breast Treated with a Checkpoint Inhibitor
por: Bernal Vaca, Laura, et al.
Publicado: (2019)

How we treat neurological toxicity from immune checkpoint inhibitors
por: Spain, Lavinia, et al.
Publicado: (2019)

Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
por: Spillane, Susan, et al.
Publicado: (2020)

Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis
por: Kiss, Igor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_57tse2cr9ipv67det9rdo90vn8